Results 231 to 240 of about 21,327 (316)

Humoral Immune Response Following COVID-19 Vaccination in Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]

Vaccines (Basel)
Kodal LS, Holm-Yildiz S, Hamm SR, Pérez-Alós L, Hansen CB, Pries-Heje MM, Heftdal LD, Hasselbalch RB, Madsen JR, Frikke-Schmidt R, Hilsted LM, Sørensen E, Ostrowski SR, Bundgaard H, Garred P, Iversen K, Nielsen SD, Vissing J, Dysgaard T.   +18 more
europepmc   +1 more source

Intravenous immunoglobulin–induced thrombocytopenia in patient with chronic inflammatory demyelinating polyneuropathy

, 2019
Takeo Sato, Shusaku Omoto, Asako Onda, Kenichiro Sakai, Hidetaka Mitsumura, Yasuyuki Iguchi   +5 more
openalex   +2 more sources

Conduction Block Detection in Dysimmune Neuropathy: Hypothetical Pathophysiological ‘Truth’ Versus Clinical Pragmatism

European Journal of Neurology, Volume 33, Issue 1, January 2026.
Yusuf A. Rajabally, Ahmad Al‐Areed
wiley   +1 more source

Research on the Side Effects of Intravenous Methylprednisolone in Hospitalized Pediatric Patients With Neurological Diseases

Journal of Clinical Pharmacy and Therapeutics, Volume 2026, Issue 1, 2026.
Background High‐dose methylprednisolone pulse therapy is being increasingly used in the treatment of neurological disorders; however, there is still a lack of studies on the side effects associated with this treatment regimen in the context of neurological diseases.
Baotian Wang, Shunxin Wang, Li Yang, Junhong Jiang, Ran Hua, Jiulai Tang, De Wu, Yue Xu   +7 more
wiley   +1 more source

Neurofilament Light Chain Levels as Diagnostic and Prognostic Biomarkers in Guillain-Barré Syndrome: An Updated Systematic Review and Meta-Analysis. [PDF]

Neurol Ther
Siconolfi G, Vitali F, Sciarrone MA, Guglielmino V, Primiano G, Luigetti M.   +5 more
europepmc   +1 more source

The Use of Botulinum Toxin Injections in Peripheral Neuropathic Pain: A Systematic Review of Efficacy and Safety Outcomes

Pain Research and Management, Volume 2026, Issue 1, 2026.
Peripheral neuropathic pain (PNP), a chronic condition resulting from nerve damage and characterized by altered sensory signaling and central sensitization, poses significant therapeutic challenges. Botulinum toxin (BTX), known for neuromuscular blockades, also exhibits analgesic properties, prompting its investigation for PNP management.
Domenico Antonio Restivo, Andrea Calderone, Angelo Quartarone, Rocco Salvatore Calabrò, Antongiulio Bruschetta, Stefano Tamburin   +5 more
wiley   +1 more source

Extracorporeal therapy procedures (plasma exchange and immunoadsorption) in chronic inflammatory demyelinating polyneuropathies (CIDP)- a database analysis. [PDF]

BMC Neurol
Mahlberg M, Dorst J, Elmas Z, Haase U, Heming M, Müller-Miny L, Meyer Zu Hörste G, Stettner M, Then Bergh F, Baum P, Disease-Related Competence Network Peripheral Nervous System (KKPNS).   +10 more
europepmc   +1 more source

Case Report: Length-dependent Small Fiber Polyneuropathy Caused by Coxsackie and Influenza Virus Co- Infection

, 2019
Nina Tsakadze, Jelena Catania, Michael Hoffmann, Lourdes Benes-Lima, Álvaro G. Estévez, María Clara Franco, Fabian Rossi, A Chan, E Wilder-Smith, A Terkelsen, P Karlsson, G Lauria, R Freeman, N Finnerup, G Pavesi, F Gemignani, G Macaluso, P Ventrua, G Magnani, P Ghosh, S Mitra, R Fealey, N Crum-Cianflone, A Hovaguimian, C Gibbons   +24 more
openalex   +2 more sources

Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy. [PDF]

Eur J Neurol
Kodal LS, Duno M, Dysgaard T.
europepmc   +1 more source

Management Of Organophosphorous Induced Polyneuropathy With Ayurvedic Protocol – A Case Report

Dr M V Sreenivas Rao
openalex   +2 more sources